Form 4: Replimune Director Sells Shares to Cover Taxes

Philip Astley-Sparke, a Director at Replimune Group, Inc., reported a transaction involving the sale of 17,657 shares of common stock to cover tax withholding obligations.

Summary

• Philip Astley-Sparke, a Director at Replimune Group, Inc., sold 17,657 shares of common stock on May 18, 2026.
• The sale was executed at a weighted average price of $5.08 per share, with individual transactions ranging from $5.02 to $5.08.
• These shares were sold to cover tax withholding obligations related to the partial vesting of Restricted Stock Units (RSUs).
• This transaction was made under an irrevocable 'sell to cover' provision in the RSU award agreements and was not a discretionary sale.
• Following this transaction, Astley-Sparke beneficially owns 1,412,414 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction was a mandatory 'sell to cover' for tax purposes and not indicative of a change in the insider's conviction about the company's prospects.

Negatives

• A director sold a portion of their holdings, although this was to cover tax obligations and not a discretionary sale.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions and this specific event, a 'sell to cover' for tax obligations, is a common occurrence when equity awards vest.

Stakeholder Impact

• Shareholders: The sale is a routine tax-related event and not a discretionary sale, thus unlikely to significantly impact share price or investor sentiment.

Key Dates

Keywords

Replimune Group, REPL, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Director Transaction